Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism

Table 2

Cardiovascular magnetic resonance parameters of control and severe hypothyroidism groups.

	Control group (n = 17)	Severe hypothyroidism group (n = 25)	value
BSA, m^2	1.65 ± 0.04	1.73 ± 0.03	0.079
EF, %	60.46 ± 1.12	60.12 ± 1.71	0.882
EDV, mL/m^2	55.44 ± 2.70	53.65 ± 1.51	0.538
ESV, mL/m^2	21.85 ± 1.62	21.50 ± 1.28	0.865
SV, mL/m^2	33.68 ± 1.39	32.15 ± 0.95	0.354
CI, L/min/m^2	2.35 ± 0.09	2.16 ± 0.08	0.133
LVMI, g/m^2	47.80 (39.25, 54.30)	51.65 (46.95, 60.30)	0.146
PET, ms	135.00 (119.60, 149.00)	156.35 (126.98, 176.35)	0.254
PFT, ms	145.15 (110.23 158.13)	158.60 (119.55, 180.20)	0.190
PER, EDV/s	3.50 (3.20, 3.70)	3.30 (3.00, 3.80)	0.258
PFR, EDV/s	4.10 (3.45, 4.55)	3.40 (2.90, 3.90)	0.035
Native T1 value, ms	1063.09 ± 8.72	1192.95 ± 17.83	≤0.001
Pericardial effusion, n	0	10	—

Data are expressed as mean ± SME or median (interquartile range) unless stated otherwise. .